319 related articles for article (PubMed ID: 34830300)
1. MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy.
Rapanotti MC; Cugini E; Nuccetelli M; Terrinoni A; Di Raimondo C; Lombardo P; Costanza G; Cosio T; Rossi P; Orlandi A; Campione E; Bernardini S; Blot-Chabaud M; Bianchi L
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830300
[TBL] [Abstract][Full Text] [Related]
2. Minimal Residual Disease in Melanoma:molecular characterization of in transit cutaneous metastases and Circulating Melanoma Cells recognizes an expression panel potentially related to disease progression.
Rapanotti MC; Viguria TMS; Spallone G; Terrinoni A; Rossi P; Costanza G; Campione E; Lombardo P; Pathirannehalage CD; Orlandi A; Bernardini S; Bianchi L
Cancer Treat Res Commun; 2020; 25():100262. PubMed ID: 33338742
[TBL] [Abstract][Full Text] [Related]
3. Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma.
Rapanotti MC; Suarez Viguria TM; Costanza G; Ricozzi I; Pierantozzi A; Di Stefani A; Campione E; Bernardini S; Chimenti S; Orlandi A; Bianchi L
Arch Dermatol Res; 2014 Aug; 306(6):527-37. PubMed ID: 24902661
[TBL] [Abstract][Full Text] [Related]
4. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.
Jean D; Gershenwald JE; Huang S; Luca M; Hudson MJ; Tainsky MA; Bar-Eli M
J Biol Chem; 1998 Jun; 273(26):16501-8. PubMed ID: 9632718
[TBL] [Abstract][Full Text] [Related]
5. Stem-Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients.
Rapanotti MC; Campione E; Suarez Viguria TM; Spallone G; Costanza G; Rossi P; Orlandi A; Valenti P; Bernardini S; Bianchi L
Front Mol Biosci; 2020; 7():92. PubMed ID: 32548126
[TBL] [Abstract][Full Text] [Related]
6. Ectopic expression of MCAM/MUC18 increases in vitro motility and invasiveness, but decreases in vivo tumorigenesis and metastasis of a mouse melanoma K1735-9 subline in a syngeneic mouse model.
Wu GJ
Clin Exp Metastasis; 2016 Dec; 33(8):817-828. PubMed ID: 27510563
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic targeting of soluble CD146/MCAM with the M2J-1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146-positive invasive tumors.
Stalin J; Traboulsi W; Vivancos-Stalin L; Nollet M; Joshkon A; Bachelier R; Guillet B; Lacroix R; Foucault-Bertaud A; Leroyer AS; Dignat-George F; Bardin N; Blot-Chabaud M
Int J Cancer; 2020 Sep; 147(6):1666-1679. PubMed ID: 32022257
[TBL] [Abstract][Full Text] [Related]
8. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes.
Pickl WF; Majdic O; Fischer GF; Petzelbauer P; Faé I; Waclavicek M; Stöckl J; Scheinecker C; Vidicki T; Aschauer H; Johnson JP; Knapp W
J Immunol; 1997 Mar; 158(5):2107-15. PubMed ID: 9036955
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3 Is a Natural Binding Ligand of MCAM (CD146, MUC18) in Melanoma Cells and Their Interaction Promotes Melanoma Progression.
Pang Y; Maxwell E; Sindrewicz-Goral P; Shapanis A; Li S; Morgan M; Yu LG
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291660
[TBL] [Abstract][Full Text] [Related]
10. Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression.
Zigler M; Villares GJ; Dobroff AS; Wang H; Huang L; Braeuer RR; Kamiya T; Melnikova VO; Song R; Friedman R; Alani RM; Bar-Eli M
Cancer Res; 2011 May; 71(10):3494-504. PubMed ID: 21467165
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis.
Melnikova VO; Balasubramanian K; Villares GJ; Dobroff AS; Zigler M; Wang H; Petersson F; Price JE; Schroit A; Prieto VG; Hung MC; Bar-Eli M
J Biol Chem; 2009 Oct; 284(42):28845-55. PubMed ID: 19703903
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 interacts with the cell-surface glycoprotein CD146 (MCAM, MUC18) and induces secretion of metastasis-promoting cytokines from vascular endothelial cells.
Colomb F; Wang W; Simpson D; Zafar M; Beynon R; Rhodes JM; Yu LG
J Biol Chem; 2017 May; 292(20):8381-8389. PubMed ID: 28364041
[TBL] [Abstract][Full Text] [Related]
13. Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression.
Reid AL; Millward M; Pearce R; Lee M; Frank MH; Ireland A; Monshizadeh L; Rai T; Heenan P; Medic S; Kumarasinghe P; Ziman M
Br J Dermatol; 2013 Jan; 168(1):85-92. PubMed ID: 23013138
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Hsp27 in a human melanoma cell line: regulation of E-cadherin, MUC18/MCAM, and plasminogen activator (PA) system.
Aldrian S; Kindas-Mügge I; Trautinger F; Fröhlich I; Gsur A; Herbacek I; Berger W; Micksche M
Cell Stress Chaperones; 2003; 8(3):249-57. PubMed ID: 14984058
[TBL] [Abstract][Full Text] [Related]
15. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
[TBL] [Abstract][Full Text] [Related]
16. The multifaceted role of CD146/MCAM in the promotion of melanoma progression.
Lei X; Guan CW; Song Y; Wang H
Cancer Cell Int; 2015; 15(1):3. PubMed ID: 25685061
[TBL] [Abstract][Full Text] [Related]
17. Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice.
Schlagbauer-Wadl H; Jansen B; Müller M; Polterauer P; Wolff K; Eichler HG; Pehamberger H; Konak E; Johnson JP
Int J Cancer; 1999 Jun; 81(6):951-5. PubMed ID: 10362144
[TBL] [Abstract][Full Text] [Related]
18. Identification of the elements regulating the expression of the cell adhesion molecule MCAM/MUC18. Loss of AP-2 is not required for MCAM expression in melanoma cell lines.
Mintz-Weber CS; Johnson JP
J Biol Chem; 2000 Nov; 275(44):34672-80. PubMed ID: 10938273
[TBL] [Abstract][Full Text] [Related]
19. Melanoma-associated adhesion molecule MUC18/MCAM (CD146) and transcriptional regulator mader in normal human CNS.
Schwarz MJ; Müller N; Körschenhausen D; Kirsch KH; Penning R; Ackenheil M; Johnson JP; Hampel H
Neuroimmunomodulation; 1998; 5(5):270-6. PubMed ID: 9730695
[TBL] [Abstract][Full Text] [Related]
20. Enforced expression of MCAM/MUC18 increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model.
Wu GJ; Fu P; Wang SW; Wu MW
Mol Cancer Res; 2008 Nov; 6(11):1666-77. PubMed ID: 19010815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
